Centiva Capital LP Acquires 36,324 Shares of Sabra Health Care REIT, Inc. (NASDAQ:SBRA)

Centiva Capital LP increased its holdings in shares of Sabra Health Care REIT, Inc. (NASDAQ:SBRA) by 59.1% in the third quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 97,798 shares of the real estate investment trust’s stock after purchasing an additional 36,324 shares during the quarter. Centiva Capital LP’s holdings in Sabra Health Care REIT were worth $1,820,000 as of its most recent filing with the SEC.

Other hedge funds have also recently bought and sold shares of the company. Principal Financial Group Inc. lifted its stake in Sabra Health Care REIT by 0.8% in the 3rd quarter. Principal Financial Group Inc. now owns 21,573,436 shares of the real estate investment trust’s stock valued at $401,479,000 after acquiring an additional 167,069 shares in the last quarter. Charles Schwab Investment Management Inc. lifted its position in Sabra Health Care REIT by 8.4% during the 3rd quarter. Charles Schwab Investment Management Inc. now owns 4,701,881 shares of the real estate investment trust’s stock worth $87,502,000 after buying an additional 365,855 shares in the last quarter. LSV Asset Management boosted its stake in shares of Sabra Health Care REIT by 2.5% during the 2nd quarter. LSV Asset Management now owns 4,380,815 shares of the real estate investment trust’s stock worth $67,465,000 after buying an additional 104,800 shares during the last quarter. Dimensional Fund Advisors LP boosted its stake in shares of Sabra Health Care REIT by 3.8% during the 2nd quarter. Dimensional Fund Advisors LP now owns 3,394,562 shares of the real estate investment trust’s stock worth $52,275,000 after buying an additional 124,825 shares during the last quarter. Finally, APG Asset Management US Inc. grew its holdings in shares of Sabra Health Care REIT by 28.9% in the 2nd quarter. APG Asset Management US Inc. now owns 2,562,962 shares of the real estate investment trust’s stock valued at $39,495,000 after acquiring an additional 575,000 shares in the last quarter. 99.40% of the stock is currently owned by institutional investors and hedge funds.

Sabra Health Care REIT Trading Up 0.4 %

SBRA stock opened at $18.45 on Wednesday. Sabra Health Care REIT, Inc. has a one year low of $12.83 and a one year high of $20.03. The stock has a market cap of $4.37 billion, a price-to-earnings ratio of 45.03, a price-to-earnings-growth ratio of 2.31 and a beta of 1.24. The company has a fifty day moving average price of $18.62 and a two-hundred day moving average price of $16.88. The company has a debt-to-equity ratio of 0.90, a current ratio of 4.16 and a quick ratio of 4.16.

Sabra Health Care REIT (NASDAQ:SBRA) last announced its earnings results on Thursday, October 31st. The real estate investment trust reported $0.13 EPS for the quarter, missing the consensus estimate of $0.35 by ($0.22). The company had revenue of $178.00 million for the quarter, compared to the consensus estimate of $177.19 million. Sabra Health Care REIT had a return on equity of 3.51% and a net margin of 14.20%. During the same period in the previous year, the firm posted $0.34 EPS. Equities analysts anticipate that Sabra Health Care REIT, Inc. will post 1.39 EPS for the current year.

Sabra Health Care REIT Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Friday, November 29th. Investors of record on Friday, November 15th were paid a $0.30 dividend. The ex-dividend date was Friday, November 15th. This represents a $1.20 annualized dividend and a yield of 6.50%. Sabra Health Care REIT’s dividend payout ratio (DPR) is presently 292.69%.

Analyst Upgrades and Downgrades

Several brokerages recently commented on SBRA. Wells Fargo & Company raised Sabra Health Care REIT from an “equal weight” rating to an “overweight” rating and increased their price target for the company from $16.00 to $20.00 in a research report on Tuesday, October 1st. Citigroup raised Sabra Health Care REIT from a “neutral” rating to a “buy” rating and increased their price objective for the company from $17.00 to $20.00 in a report on Friday, September 13th. Truist Financial raised their target price on shares of Sabra Health Care REIT from $16.00 to $18.00 and gave the company a “buy” rating in a research note on Wednesday, September 4th. Finally, Scotiabank increased their price target on shares of Sabra Health Care REIT from $17.00 to $18.00 and gave the company a “sector perform” rating in a research note on Friday, October 11th. One investment analyst has rated the stock with a hold rating and six have given a buy rating to the stock. Based on data from MarketBeat.com, Sabra Health Care REIT currently has an average rating of “Moderate Buy” and an average price target of $18.71.

About Sabra Health Care REIT

As of September 30, 2023, Sabra's investment portfolio included 377 real estate properties held for investment (consisting of (i) 240 Skilled Nursing/Transitional Care facilities, (ii) 43 senior housing communities (Senior Housing – Leased), (iii) 61 senior housing communities operated by third-party property managers pursuant to property management agreements (Senior Housing – Managed), (iv) 18 Behavioral Health facilities and (v) 15 Specialty Hospitals and Other facilities), 12 investments in loans receivable (consisting of two mortgage loans and 10 other loans), five preferred equity investments and two investments in unconsolidated joint ventures.